MAP3K3 and non-small cell lung carcinoma: ERK5 and EGFR also showed increased protein levels in NSCLC, and we hypothesized that the EGFR‐TRAF4‐MEKK3‐ERK5 signal axis might have positive feedback on the expression of ERK5 and EGFR.